Indian generic drugmaker Claris Lifesciences Ltd said on Thursday it was not in talks to sell its stake in injectable drugs business, and has not considered such an action.
The company issued the statement in response to a newspaper report that said several large pharmaceutical companies were in a race to buy Claris's sterile injectables business.
Claris said it had "neither considered nor taken any decision in this regard."
The company's shares rose as much as 20 per cent to Rs 248.20 rupees on Thursday, while the broader NSE index was up 0.64 per cent.
More Like This
Published on February 12, 2015
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.